GB Patent

GB201216018D0 — Pharmacologically active compounds

Assigned to Cancer Research Technology Ltd · Expires 2012-10-24 · 14y expired

What this patent protects

Patent listed against chembl-chembl1444.

Drugs covered by this patent

Patent Metadata

Patent number
GB201216018D0
Jurisdiction
GB
Classification
—
Expires
2012-10-24
Drug substance claim
No
Drug product claim
No
Assignee
Cancer Research Technology Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.